Posted in

Are there any alternative tests to TCT?

Hey everyone, if you’ve been part of the women’s health space for even a minute, you’ve definitely heard of TCT tests—those liquid-based Pap smears that’ve been the go-to for cervical cancer screening for years. As someone who works at a TCT supply company, I get asked this question all the time: “What other tests are out there besides TCT?” It makes sense—healthcare providers are always looking for tools that fit their clinic’s needs, and patients want to know there are options beyond what’s been marketed as the standard. I’ve spent years talking to OB/GYNs, clinic managers, and lab techs about this, so let me break down what actually matters when it comes to alternative tests to TCT—no jargon, just real talk. TCT

First, let’s get one thing straight: TCT isn’t obsolete. It’s still one of the most reliable ways to catch abnormal cervical cells early, which is why our company’s been supplying it to clinics across the country for so long. But “alternative” doesn’t mean “replacement”—it means tools that fill different gaps, work better for specific patient populations, or pair with TCT to make screening more effective. Let’s start with the big one that everyone’s talking about now: HPV testing.

Wait, no, not just HPV—co-testing. A lot of providers do co-testing: TCT plus high-risk HPV (hrHPV) testing. The idea is that HPV causes almost all cervical cancers, so testing for the virus that’s the root cause, alongside looking for actual cell changes, gives a two-layer check. Is that an alternative to TCT? Sometimes. For people over 30, the CDC actually recommends co-testing every 5 years as a primary screening option, or HPV testing alone every 5 years. But here’s the catch: HPV testing can’t tell you if the infection is high-risk and already caused cell damage—it just says “you have HPV.” Most HPV infections clear on their own (like a cold), so positive HPV results often lead to more tests, not immediate action. That’s a big difference from TCT, which shows you exactly if cells are abnormal—so providers can act faster if needed. I’ve had a clinic tell me that switching to HPV alone for routine screening ended up with more follow-up calls from patients panicking about positive results that weren’t actually precancerous. It’s not that HPV is bad, it’s that it’s not a one-for-one alternative to TCT.

Another alternative: conventional Pap smears. Wait, hold on—TCT is a type of Pap smear, right? People used to do the old-school Pap where a swab is rubbed on a slide, smeared, and sent to the lab. TCT came along in the 90s to fix the conventional Pap’s flaws: it’s more accurate, has less “unsatisfactory” results (where the lab can’t read the sample because it’s smeared too thin or has blood/mucus), and picks up more precancerous cells. But some smaller clinics, especially in rural areas with tight budgets, still use conventional Pap because it’s cheaper upfront. Is it a real alternative? Yeah, but only if you don’t mind a higher rate of inconclusive results. I’ve talked to a lab tech who said they get 10-15% unsatisfactory conventional Pap samples, vs. less than 2% for TCT. For busy clinics, that’s a huge waste of time and supplies—so conventional Pap is more of a “budget alternative” for places that can’t swing TCT, not a better or equivalent test.

Then there’s visual tests. VIA and VILI, for anyone who’s worked in low-resource settings where lab equipment is scarce. VIA is visual inspection with acetic acid—they swab the cervix with vinegar, and abnormal cells turn white. VILI is visual inspection with Lugol’s iodine, where normal cells turn brown and abnormal ones don’t. These are super cheap, no lab needed, and work in places where you can’t send samples out for testing. But here’s the thing: they’re way less accurate. Studies show VIA has a sensitivity of around 55-80% for precancerous cells, vs. TCT’s 90%+ sensitivity. So they’re great for areas with no access to labs, but not a replacement for TCT in places where lab testing is possible. I once worked with a non-profit that brought VIA kits to a rural clinic in Africa, but they still ordered TCT supplies to send samples to a lab for confirmation because they didn’t want to miss any cases.

Wait, what about liquid-based cytology alternatives from other companies? No, I mean different types of tests entirely, like cervical biopsies? No, biopsies are diagnostic, not screening. The point of screening tests is to catch issues early before they turn into cancer, so biopsies are for when a screening comes back abnormal. Let’s also mention something that’s been popping up more lately: self-collected HPV tests. A lot of people hate the gynecologic exam, so self-collecting a sample and sending it in for HPV testing is an option. Studies show the accuracy is almost the same as provider-collected HPV, so that’s a good alternative for people who skip screening because they’re uncomfortable. But again, it’s only testing for HPV, not cell changes—so if self-collected HPV is positive, they still need to go in for a provider sample (either TCT or HPV) to check for damage. It’s a complement to TCT, not a replacement.

Let’s talk about when providers actually pick an alternative to TCT. For teens and young adults under 21, TCT is often not the first line, right? Because most HPV infections in that age group clear on their own, so testing isn’t necessary. But if a teen has an abnormal Pap before, providers might switch to HPV testing to monitor. For pregnant people? Some providers prefer TCT because it’s less likely to be affected by the changes in the cervix during pregnancy, which can make conventional Pap results harder to read. I had an OB/GYN client tell me they switched to TCT for all their pregnant patients because they had way fewer false positives than conventional Pap when people were expecting. For people with a history of abnormal results, co-testing (TCT + HPV) is the gold standard now because it’s more accurate at catching high-risk changes, so that’s more of a “better together” than an alternative.

Now, let’s bust some myths I hear all the time. “TCT is outdated, HPV is better.” No, not for everyone. For people under 30, the USPSTF says you don’t need co-testing, just TCT every 3 years, because HPV is super common in that age group and most clear on their own—testing for it would just lead to unnecessary anxiety. Another myth: “All alternative tests are cheaper than TCT.” Nope. Self-collected HPV tests are actually more expensive per test than TCT for clinics, unless you’re buying in bulk. VIA is cheap, but if you have to send a sample for confirmation, you’re adding that cost. Conventional Pap is cheaper upfront, but the cost of repeat tests for unsatisfactory samples adds up fast. I’ve crunched numbers for a small clinic that thought conventional Pap would save them $500 a quarter, but after adding in the extra lab fees for re-sampling, it ended up costing them $300 more.

As someone who’s in the thick of supplying TCT, I’m not here to bash alternatives— I’m here to give the real, on-the-ground truth that’s not in textbooks. The best test isn’t a one-size-fits-all. TCT is perfect for when you need clear, actionable results, fast. It’s great for all age groups, has the lowest rate of unsatisfactory samples, and is the standard that most labs are set up to process. But if you’re in a rural clinic with no lab access, VIA is a lifesaver. If your patients hate in-office exams, self-collected HPV is a good way to get them screened. If you’re testing someone over 30, co-testing TCT and HPV gives you the most comprehensive check.

I also want to mention that there’s new stuff coming out, like mRNA HPV tests that can tell you if an infection is active and likely to cause damage—those are still pretty new, but they might become a real alternative or complement to TCT in the next few years. But for now, TCT is still the workhorse, and alternatives are just tools that fit different needs.

At the end of the day, the goal of cervical cancer screening is to catch precancerous cells before they turn into invasive cancer. That’s it. Whether you use TCT, HPV testing, VIA, or something else, as long as you’re hitting that goal, that’s what matters. I’ve seen too many clinics make the mistake of jumping on the latest “alternative” without thinking about their patient population, their budget, and their lab capacity, and that’s when things go wrong.

If you’re a clinic manager, lab tech, or OB/GYN trying to figure out what test works best for your practice, I’d love to chat. We supply TCT, and we also help clinics figure out how to pair it with other tests if that makes sense for their patients. Whether you’re comparing TCT to conventional Pap, HPV testing, or visual tests, we can break down the costs, the accuracy rates, and how it fits with your workflow. No sales pitch, just real advice from someone who’s been in this space for years.

If you’re looking to streamline your cervical screening process and find the right mix of tests for your patients, don’t hesitate to reach out to discuss your specific needs. Our team is here to help you make the best choice for your clinic, no pressure, just science and practicality.

Grinder Cutting Wheel References

  1. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 186: Cervical Cancer Screening and Prevention. Obstetrics & Gynecology, 2017.
  2. United States Preventive Services Task Force (USPSTF). Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 2020.
  3. World Health Organization (WHO). Global Guidelines for the Prevention and Control of Cervical Cancer, 2021.
  4. Sasieni, P., et al. Accuracy of Cervical Screening Tests for the Detection of Precancerous Lesions: A Systematic Review and Meta-Analysis. Lancet Oncology, 2017.
  5. Centers for Disease Control and Prevention (CDC). Cervical Cancer Screening Guidelines, 2023.

Yongkang Delun Grinding Tools Co., Ltd.
Yongkang Delun Grinding Tools Co., Ltd. is well-known as one of the leading diamond cutting blade manufacturers and suppliers in China since 1988. If you’re going to wholesale high quality diamond cutting blade made in China, welcome to get more information from our factory.
Address: No.101th Tongtai Road, Zhiying Industrial Area, Yongkang City, Zhejiang Province, China
E-mail: Sales02@delungrinding.com
WebSite: https://www.delunabrasives.com/